Correlation Between 84858DAA6 and Acumen Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 84858DAA6 and Acumen Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 84858DAA6 and Acumen Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between US84858DAA63 and Acumen Pharmaceuticals, you can compare the effects of market volatilities on 84858DAA6 and Acumen Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 84858DAA6 with a short position of Acumen Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of 84858DAA6 and Acumen Pharmaceuticals.

Diversification Opportunities for 84858DAA6 and Acumen Pharmaceuticals

0.27
  Correlation Coefficient

Modest diversification

The 3 months correlation between 84858DAA6 and Acumen is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding US84858DAA63 and Acumen Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acumen Pharmaceuticals and 84858DAA6 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on US84858DAA63 are associated (or correlated) with Acumen Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acumen Pharmaceuticals has no effect on the direction of 84858DAA6 i.e., 84858DAA6 and Acumen Pharmaceuticals go up and down completely randomly.

Pair Corralation between 84858DAA6 and Acumen Pharmaceuticals

Assuming the 90 days trading horizon US84858DAA63 is expected to generate 0.96 times more return on investment than Acumen Pharmaceuticals. However, US84858DAA63 is 1.05 times less risky than Acumen Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Acumen Pharmaceuticals is currently generating about -0.24 per unit of risk. If you would invest  9,060  in US84858DAA63 on November 8, 2024 and sell it today you would lose (10.00) from holding US84858DAA63 or give up 0.11% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy47.62%
ValuesDaily Returns

US84858DAA63  vs.  Acumen Pharmaceuticals

 Performance 
       Timeline  
US84858DAA63 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in US84858DAA63 are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, 84858DAA6 may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Acumen Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Acumen Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

84858DAA6 and Acumen Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 84858DAA6 and Acumen Pharmaceuticals

The main advantage of trading using opposite 84858DAA6 and Acumen Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 84858DAA6 position performs unexpectedly, Acumen Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acumen Pharmaceuticals will offset losses from the drop in Acumen Pharmaceuticals' long position.
The idea behind US84858DAA63 and Acumen Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume